| Year |
Citation |
Score |
| 2023 |
Cui J, Christin JR, Reisz JA, Cendali FI, Sanawar R, Coutinho De Miranda M, D'Alessandro A, Guo W. Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Science Advances. 9: eadh1891. PMID 38039374 DOI: 10.1126/sciadv.adh1891 |
0.619 |
|
| 2023 |
Liu Y, John P, Nishitani K, Cui J, Nishimura CD, Christin JR, Couturier N, Ren X, Wei Y, Pulanco MC, Galbo PM, Zhang X, Fu W, Cui W, Bartholdy BA, et al. A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression. Developmental Cell. PMID 37963469 DOI: 10.1016/j.devcel.2023.10.010 |
0.613 |
|
| 2023 |
Cui J, Zhang C, Lee JE, Bartholdy BA, Yang D, Liu Y, Erler P, Galbo PM, Hodge DQ, Huangfu D, Zheng D, Ge K, Guo W. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state. Nature Cell Biology. PMID 36604594 DOI: 10.1038/s41556-022-01045-0 |
0.594 |
|
| 2021 |
Cui J, Guo W. Establishment and long-term culture of mouse mammary stem cell organoids and breast tumor organoids. Star Protocols. 2: 100577. PMID 34124696 DOI: 10.1016/j.xpro.2021.100577 |
0.587 |
|
| 2018 |
Jia L, Zhang J, Ma T, Guo Y, Yu Y, Cui J. The Function of Fucosylation in Progression of Lung Cancer. Frontiers in Oncology. 8: 565. PMID 30619732 DOI: 10.3389/fonc.2018.00565 |
0.311 |
|
| 2018 |
Hodge DQ, Cui J, Gamble MJ, Guo W. Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. Scientific Reports. 8: 841. PMID 29339820 DOI: 10.1038/S41598-018-19364-4 |
0.573 |
|
| 2017 |
Cui J, Xie X. Non-coding RNAs: emerging regulatory factors in the derivation and differentiation of mammalian parthenogenetic embryonic stem cells. Cell Biology International. PMID 28220611 DOI: 10.1002/cbin.10751 |
0.346 |
|
| 2017 |
Liu W, Yin L, Yan X, Cui J, Liu W, Rao Y, Sun M, Wei Q, Chen F. Directing the Differentiation of Parthenogenetic Stem Cells into Tenocytes for Tissue-Engineered Tendon Regeneration. Stem Cells Translational Medicine. 6: 196-208. PMID 28170171 DOI: 10.5966/sctm.2015-0334 |
0.344 |
|
| 2016 |
Cui J, Hollmén M, Li L, Chen Y, Proulx ST, Reker D, Schneider G, Detmar M. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate. Oncotarget. PMID 27894093 DOI: 10.18632/Oncotarget.13537 |
0.598 |
|
| 2016 |
Rao Y, Cui J, Yin L, Liu W, Liu W, Sun M, Yan X, Wang L, Chen F. Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent. Stem Cell Research & Therapy. 7: 156. PMID 27770834 DOI: 10.1186/s13287-016-0407-z |
0.314 |
|
| 2016 |
Liu W, Yin L, Yan X, Cui J, Liu W, Rao Y, Sun M, Wei Q, Chen F. Directing the Differentiation of Parthenogenetic Stem Cells Into Tenocytes for Tissue-Engineered Tendon Regeneration. Stem Cells Translational Medicine. PMID 27538430 DOI: 10.5966/sctm.2015-0334 |
0.336 |
|
| 2014 |
Liu W, Yang X, Yan X, Cui J, Liu W, Sun M, Rao Y, Chen F. Directing parthenogenetic stem cells differentiate into adipocytes for engineering injectable adipose tissue. Stem Cells International. 2014: 423635. PMID 25587287 DOI: 10.1155/2014/423635 |
0.31 |
|
| 2013 |
Yan X, Yang Y, Liu W, Geng W, Du H, Cui J, Xie X, Hua J, Yu S, Li L, Chen F. Differentiation of neuron-like cells from mouse parthenogenetic embryonic stem cells. Neural Regeneration Research. 8: 293-300. PMID 25206669 DOI: 10.3969/j.issn.1673-5374.2013.04.001 |
0.367 |
|
| 2009 |
Zhang Y, Li Q, Zhu F, Cui J, Li K, Li Q, Wang R, Wang W, Wang W, Yan W. Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues. Journal of Experimental & Clinical Cancer Research : Cr. 28: 111. PMID 19664239 DOI: 10.1186/1756-9966-28-111 |
0.336 |
|
| Show low-probability matches. |